Related Experiment Video

Updated: Jun 16, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

[Outcome differences in pediatric patients with type 1 diabetes mellitus depending on their HLA-DQ genotypes]

Miguel Angel García Cabezas1, Patricio Giralt Muiña, Bárbara Fernández Valle

  • 1Servicio de Pediatría, Hospital General, Ciudad Real, España. partisanocabezas@gmail.com

Medicina Clinica
|February 9, 2010
PubMed

Insights

Pediatric patients with type 1 diabetes mellitus and specific HLA-DQ genotypes show earlier disease onset and altered blood pressure. These findings highlight the link between genetic predisposition and clinical outcomes in type 1 diabetes.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease affecting children and adolescents.
  • Human Leukocyte Antigen (HLA) -DQ genotypes are associated with T1DM susceptibility.
  • Understanding the relationship between HLA-DQ genotypes and T1DM outcomes is crucial for personalized management.

Purpose of the Study:

  • To investigate the association between HLA-DQ genotypes and short-term outcomes in pediatric patients with T1DM.
  • To explore the influence of diabetogenic risk groups, defined by HLA-DQ genotypes, on disease onset and progression.

Main Methods:

  • A descriptive epidemiologic study was conducted on 129 pediatric patients (<16 years) with T1DM.
  • Patients' HLA-DQ genotypes were analyzed and categorized into diabetogenic risk groups.
  • Clinical and analytical parameters, including disease onset, pancreatic reserve, and chronic complications, were monitored over 3 years.

Main Results:

  • A high prevalence (93.8%) of diabetes-risk HLA-DQ genotypes was observed in the study cohort.
  • Patients in risk group III experienced earlier disease onset and demonstrated reduced pancreatic reserve.
  • Significant differences in systolic and diastolic blood pressure were noted in risk group III, and diastolic blood pressure in risk group I during follow-up.

Conclusions:

  • HLA-DQ risk group III is associated with earlier onset of T1DM in pediatric patients.
  • Patients in risk group III exhibit significant alterations in systolic and diastolic blood pressure during the follow-up period.
  • Genetic predisposition, indicated by HLA-DQ genotypes, influences both the clinical presentation and cardiovascular parameters in pediatric T1DM.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...